American College of Cardiology
Avatar

Is Rivaroxaban Beneficial in Patients With Peripheral Artery Disease Who Had Undergone Lower-extremity Revascularization? What Are the Possible Risks of the Drug?

By American College of Cardiology FEATURING David Adams, Valentin Fuster, Roxana Mehran, Anuradha Lala-Trindade, Vivek Reddy
By American College of Cardiology FEATURING David Adams, Valentin Fuster, Roxana Mehran, Anuradha Lala-Trindade, Vivek Reddy
399 views
June 8, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
13:46
NY Endovascular Summit

Medical Management of Peripheral Arterial Disease

Feat. H. Kamran
35:26
McMaster University Department of Medicine

Bridging the PAD Gap: A Collaborative Approach to Improving Peripher…

Feat. R. Joseph
10:56
NY Endovascular Summit

Medical Management of PAD: Current Data and Recommendations

Feat. J. Olin
33:47
Cordis

Practical Approach to Radial Artery Access

Feat. G. Adams
09:19
The North American Thrombosis Forum (NATF)

Clot Chronicles: Peripheral Artery Disease — What Clinicians Should …

Feat. M. Mcdermott
29:07
World Stroke Organization

Cervical Artery Dissection: Diagnosis, Treatment and Outcomes Panel …

Feat. V. Pujol Lereis, S. Salehi Omran, S. Yaghi, S. Engelter, H. Markus
23:39
ARCH Advanced Revascularization Symposium

Biggest Vascular Papers/Presentations of 2022-2023

Feat. C. Walker
10:33
NY Endovascular Summit

Femoropopliteal Artery Disease and Treatment Options / Literature Re…

Feat. S. Parikh
15:14
Cardiometabolic Health Congress (CMHC)

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is th…

Feat. D. Bhatt
35:24
37th Annual Advances in Heart Disease

ICU Management for COVID 19 Patients: What Are the Anticoagulation S…

Feat. A. Gomez, P. Hsue
09:45
Marc Bonaca

VOYAGER PAD Trial: Protecting the Patient Undergoing Lower Extremity…

13:35
NY Endovascular Summit

Maximal Medical Therapy in Peripheral Arterial Disease

Feat. D. Kadian-Dodov
17:28
NY Endovascular Summit

Update on Antiplatelet and Antithrombotic Use in Atherosclerosis

Feat. R. Mehran, A. Lee, P. Krishnan
13:08
Jefferson Health

Risk Factors and Medical Management of PAD

Feat. T. Galanis
27:53
NY Endovascular Summit

Treating Peripheral Artery Disease: Beyond Intervention

Feat. J. Olin
09:30
UPMC

Thoracic Outlet Syndrome in Adolescents Is a Real Challenge

Feat. M. Singh
15:54
Houston Methodist DeBakey Heart and Vascular Center

Peripheral Artery Disease: Hard to Detect and Treat

Feat. J. P. Cooke
12:36
PERT Consortium 2021

DOAC-Associated Bleeding Management

Feat. D. Siegal
21:06
The North American Thrombosis Forum (NATF)

Post-PTE Anticoagulation, Warfarin vs. DOACs: End of the INR?

Feat. I. Robbins